Insight Molecular Diagnostics Inc. Loss Contingency, Damages Awarded, Value
Insight Molecular Diagnostics Inc. (IMDX) reported Loss Contingency, Damages Awarded, Value of $300.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-14.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LossContingencyDamagesAwardedValue · last filed 2020-03-26
- Insight Molecular Diagnostics Inc. loss contingency, damages awarded, value for the quarter ending 2019-03-31 was $300.00K.
- Insight Molecular Diagnostics Inc. loss contingency, damages awarded, value for fiscal 2018 was $300.00K.
| Period end | Loss Contingency, Damages Awarded, Value 1 month | Loss Contingency, Damages Awarded, Value 3 month | Loss Contingency, Damages Awarded, Value 12 month |
|---|---|---|---|
| 2019-03-31 | $300.00K 10-K · filed 2020-03-26 | $300.00K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $300.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |